Inspire Medical Systems Inc. (INSP) has issued a recall of its Inspire IV Implantable Pulse Generator (IPG) Model 3028 due to a critical manufacturing defect. The FDA has classified this as the most serious type of recall, as the defect can lead to electrical leakage in the sensing circuit post-implantation. This leakage can cause system malfunctions, potentially resulting in severe health consequences, including inconsistent stimulation, painful shocks or even death. There may be an urgent need for revision surgery to replace the IPG. Following the news, shares of INSP declined 3.3% during yesterday’s trading session to close at $131.44. Significance of the Recall The IPG is a crucial component of the Inspire Upper Airway Stimulation system, which is designed to maintain airway patency during sleep by delivering mild electrical stimulation to the hypoglossal nerve. The IPG works together with external programmers that allow the physician to set and adjust the therapy parameters and the patient to control the therapy's activation and intensity. Per Inspire Medical Systems, the recall of the Inspire IV Implantable Pulse Generator is of utmost importance due to the possible severe adverse health effects it can cause. A defect in this device can lead to stimulation below normal therapeutic levels, early battery depletion, inconsistent or inappropriate stimulation and painful or shocking sensations. These issues necessarily prompt identification and correction to prevent serious health risks and ensure the safety and efficacy of the therapy. In the first quarter of 2024, the company reported a 25% year-over-year increase in U.S. revenues, banking on increased market penetration of Inspire therapy. The recall of the Inspire IV IPG model 3028 might dampen the company’s future sales. Industry Prospects Per Verified Market Reports, the global implantable pulse generator market size was valued at $118.57 billion in 2023. It is anticipated to reach $188.76 billion in 2030 at a CAGR of 8.6%. The market for implantable pulse generators is expanding significantly due to advances in medical technology and the rising incidence of neurological illnesses and chronic pain. In response to patient preferences for less intrusive treatments, smaller and more effective devices with improved battery life and wireless communication are being developed. The growing need for smart features and individualized therapy is also shaping implantable pulse generator developments. Price Performance Shares of Inspire Medical have declined 35.4% so far this year compared with the industry's 19.5% decline. The S&P 500 has witnessed a 17.5% rise in the same time frame. Zacks Investment Research Image Source: Zacks Investment Research Zacks Rank & Key Picks Currently, Inspire Medical carries a Zacks Rank #4 (Sell). Some top-ranked stocks in the broader medical space are DaVita Inc. DVA, Universal Health Services UHS and Ecolab Inc. ECL. DaVita, carrying a Zacks Rank #2 (Buy) at present, has an estimated long-term growth rate of 13.6%. DVA’s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 29.4%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. DaVita’s shares have gained 43.4% compared with the industry’s 15.2% rise in the past year. Universal Health Services, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 14.80%. UHS’ earnings surpassed estimates in the trailing four quarters, with an average of 8.12%. Universal Health Services has gained 21.3% against the industry’s 20.4% decline in the past year. Ecolab, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 14.3%. ECL’s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 1.3%. Ecolab’s shares have rallied 31.3% against the industry’s 12.9% decline in the past year. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ecolab Inc. (ECL):Free Stock Analysis Report Universal Health Services, Inc. (UHS):Free Stock Analysis Report DaVita Inc. (DVA):Free Stock Analysis Report Inspire Medical Systems, Inc. (INSP):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Inspire Medical (INSP) Dips on FDA Recall of IPG Model 3028
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...